Masakazu Yamaguchi Selected Research

Masakazu Yamaguchi Research Topics

Disease

9	Neoplasms (Cancer) 03/2022 - 03/2019
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 01/2021
3	Vomiting 04/2021 - 03/2019
3	Nausea 04/2021 - 03/2019
2	Lung Neoplasms (Lung Cancer) 04/2022 - 04/2021
2	Hypersensitivity (Allergy) 02/2022 - 08/2017
2	Stomach Neoplasms (Stomach Cancer) 04/2020 - 02/2020
2	Drug-Related Side Effects and Adverse Reactions 01/2020 - 10/2019
2	Asthma (Bronchial Asthma) 01/2007 - 09/2006
1	Neutropenia 03/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2022
1	Osteosarcoma (Osteogenic Sarcoma) 02/2022
1	Ovarian Neoplasms (Ovarian Cancer) 02/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Infections 06/2021
1	Hypertension (High Blood Pressure) 04/2021
1	Atrioventricular Block 04/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Paronychia 01/2018
1	Exanthema (Rash) 01/2018
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2017
1	Respiratory Hypersensitivity 05/2007
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2007
1	Alzheimer Disease (Alzheimer's Disease) 07/2004
1	Parkinson Disease (Parkinson's Disease) 07/2004

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 02/2022 - 01/2021
3	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022 - 08/2017
3	Aprepitant (Emend)FDA Link 04/2022 - 03/2019
2	Cisplatin (Platino)FDA LinkGeneric 04/2022 - 04/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 02/2020
2	pembrolizumabIBA 01/2021 - 01/2021
2	NivolumabIBA 01/2021 - 01/2021
2	Cetuximab (Erbitux)FDA Link 01/2018 - 08/2017
1	Cytochrome P-450 CYP3AIBA 04/2022
1	AntiemeticsIBA 04/2022
1	EnzymesIBA 04/2022
1	pegfilgrastim (Neulasta)FDA Link 03/2022
1	Methotrexate (Mexate)FDA LinkGeneric 02/2022
1	Carboplatin (JM8)FDA LinkGeneric 02/2022
1	Proton Pump InhibitorsIBA 01/2022
1	Capecitabine (Xeloda)FDA Link 01/2022
1	Voriconazole (Vfend)FDA LinkGeneric 06/2021
1	letermovirIBA 06/2021
1	ErbB Receptors (EGF Receptor)IBA 04/2021
1	Gemcitabine FDA Link 04/2021
1	Monoclonal AntibodiesIBA 04/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2021
1	Investigational DrugsIBA 04/2021
1	Amlodipine (Norvasc)FDA LinkGeneric 04/2021
1	AntibodiesIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2020
1	RamucirumabIBA 04/2020
1	PlatinumIBA 04/2020
1	lenvatinibIBA 01/2020
1	Neurokinin-1 Receptor AntagonistsIBA 03/2019
1	fosaprepitant FDA Link 03/2019
1	Fentanyl (Sublimaze)FDA LinkGeneric 05/2007
1	Cholinergic Agents (Cholinergics)IBA 05/2007
1	Adenosine Triphosphate (ATP)IBA 01/2007
1	Propofol (Diprivan)FDA LinkGeneric 09/2006
1	Immunoglobulin E (IgE)IBA 09/2006
1	Anesthetics (Anesthetic Agents)IBA 09/2006
1	Selegiline (E250)FDA LinkGeneric 07/2004

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 03/2022 - 03/2019
2	Drug Tapering 03/2022 - 01/2020
2	Therapeutics 02/2022 - 01/2021
2	Aftercare (After-Treatment) 01/2021 - 01/2018
1	Injections 11/2021
1	Hematopoietic Stem Cell Transplantation 06/2021
1	Transplantation 10/2020
1	Cell Transplantation 10/2020
1	Combination Drug Therapy (Combination Chemotherapy) 08/2017
1	Premedication 08/2017
1	Anesthesia 09/2006